Clinical Trial Update: Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apapitatin in combination with SOX as palliative adjuvant chemotherapy for advanced gallbladder carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Carcinoma

Drugs mentioned

• SOX (SOX)
• apapitatin (apapitatin)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Gallbladder Carcinoma | Phase 2 | Status: UNKNOWN